Loading company…
Watertown, Massachusetts biotech developing modular proteins and antibodies for autoimmune diseases, now a Merck subsidiary.
Founded in 2016 by Alan Crane, Anthony Coyle, David H. Sachs, and Jo Viney, Pandion Therapeutics, Inc. is based in Massachusetts, US. It is a clinical-stage biotechnology company whose pipeline includes PT101, currently in Phase 1a trials. Merck & Co., Inc. fully acquired the company in 2021 for USD 60 per share in cash, a total equity value of USD 1.85 billion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in